Table 6.
CRS with comorbid anxiety (n=20) |
CRS without comorbid anxiety (n=92) |
||||
---|---|---|---|---|---|
Quality of life measures: | Mean [SD] | Relative Change |
Mean [SD] | Relative Change |
p-value |
SNOT-22 total score | −18.1[19.5] ** | 31% | −29.0[21.0] * | 52% | 0.03 |
Rhinologic symptoms | −5.4[6.4] ** | 34% | −9.0[6.3] * | 53% | 0.02 |
Extra-nasal rhinologic symptoms | −2.4[4.0] ** | 31% | −4.3[3.7] * | 52% | 0.08 |
Ear and/or facial symptoms | −4.3[3.9] * | 42% | −5.5[5.0] * | 56% | 0.28 |
Psychological dysfunction | −5.2[8.4] ** | 27% | −8.3[8.5] * | 49% | 0.19 |
Sleep dysfunction | −4.2[7.1] ** | 28% | −7.7[7.1] * | 49% | 0.04 |
RSDI total scores | −17.3[29.3] ** | 32% | −26.5[22.4] * | 57% | 0.12 |
Physical subdomain | −6.9[9.8] ** | 34% | −11.7[9.1] * | 61% | 0.05 |
Functional subdomain | −6.1[10.2] ** | 36% | −8.8[8.4] * | 59% | 0.29 |
Emotional subdomain | −4.3[12.0] | 25% | −5.9[7.6] * | 48% | 0.59 |
indicates significant postoperative improvement over time (p<0.001)
indicates significant postoperative improvement over time (p<0.050).
Negative mean scores indicate improvement over time. SD, standard deviation; SNOT-22, 22-item Sinonasal Outcome Test; RSDI, Rhinosinusitis Disability Index.